Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study
- 4 July 2015
- journal article
- research article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 34 (12), 1542-1548
- https://doi.org/10.1016/j.healun.2015.06.018
Abstract
No abstract availableKeywords
Funding Information
- Thoratec Corporation®
This publication has 19 references indexed in Scilit:
- Sixth INTERMACS annual report: A 10,000-patient databaseThe Journal of Heart and Lung Transplantation, 2014
- De Novo Aortic Insufficiency During Long-Term Support on a Left Ventricular Assist DeviceASAIO Journal, 2014
- Unexpected Abrupt Increase in Left Ventricular Assist Device ThrombosisThe New England Journal of Medicine, 2014
- Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2013
- Continuous-flow devices and percutaneous site infections: Clinical outcomesThe Journal of Heart and Lung Transplantation, 2012
- Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantationAmerican Heart Journal, 2012
- Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device RecipientsThe Annals of Thoracic Surgery, 2010
- Acquired von Willebrand Syndrome After Continuous-Flow Mechanical Device Support Contributes to a High Prevalence of Bleeding During Long-Term Support and at the Time of TransplantationJournal of the American College of Cardiology, 2010
- Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device ImplantationThe Annals of Thoracic Surgery, 2009
- Severely Impaired von Willebrand Factor-Dependent Platelet Aggregation in Patients With a Continuous-Flow Left Ventricular Assist Device (HeartMate II)Journal of the American College of Cardiology, 2009